An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321

affy—analysis of Affymetrix GeneChip data at the probe level

Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,831

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Paik, S., Tang, G., Shak, S., Kim, C., Baker, J. B., Kim, W., Cronin, M. T., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,597

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Harris, L. N., Fritsche, H. A., Mennel, R. G., Norton, L., Ravdin, P. M., Taube, S. E., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,234

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050

Genes that mediate breast cancer metastasis to the brain

Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863

Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer

Sereesongsaeng, N., McDowell, S. H., Burrows, J. F., Scott, C. J., & Burden, R. E. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01376-6 · Cited by 43

Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors

Wang, L., Londono, L. M., Cowell, J., Saatci, Ö., Aras, M., Ersan, P. G., Serra, S., Pei, H., Clift, R., Zhao, Q., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0340 · Cited by 43

Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis

Liu, F., Wu, Y., Mi, Y., Gu, L., Sang, M., & Geng, C. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152436 · Cited by 41

Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis

Mehraj, U., Alshehri, B., Khan, A. A., Bhat, A. A., Bagga, P., Wani, N. A., & Mir, M. A. (2022) · Clinical Breast Cancer · doi:10.1016/j.clbc.2022.04.008 · Cited by 40

Targeting Trop2 by Bruceine D suppresses breast cancer metastasis by blocking Trop2/β-catenin positive feedback loop

Tang, W., Hu, Y., Tu, K.-H., Gong, Z., Zhu, M., Yang, T., Sarwar, A., Dai, B., Zhang, D., Zhan, Y., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.05.012 · Cited by 41

SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer

Amelio, I., Tsvetkov, P. O., Knight, R. A., Lisitsa, A., Melino, G., & Antonov, A. V. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.12 · Cited by 41

MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis

Yang, Z., Xu, S., Jin, P., Yang, X., Li, X., Wan, D., Zhang, T., Long, S., Xiao, W., Chen, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8726 · Cited by 42

CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing

Ding, J., Guo, C., Hu, P., Chen, J., Liu, Q., Wu, X., Cao, Y., & Wu, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3680 · Cited by 41

SORBS1 suppresses tumor metastasis and improves the sensitivity of cancer to chemotherapy drug

Song, L., Chang, R., Dai, C., Wu, Y., Guo, J., Qi, M., Zhou, W., & Zhan, L. (2016) · Oncotarget · doi:10.18632/oncotarget.12851 · Cited by 40

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer

Seachrist, D. D., Sizemore, S. T., Johnson, E., Abdul‐Karim, F. W., Weber-Bonk, K. L., & Keri, R. A. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0857-y · Cited by 41

SOX11 promotes invasive growth and ductal carcinoma in situ progression

Oliemuller, E., Kogata, N., Bland, P. J., Kriplani, D., Daley, F. M., Haider, S. A., Shah, V., Sawyer, E. J., & Howard, B. A. (2017) · The Journal of Pathology · doi:10.1002/path.4939 · Cited by 43

Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells

Dinami, R., Buemi, V., Sestito, R., Zappone, A., Ciani, Y., Mano, M., Petti, E., Sacconi, A., Blandino, G., Giacca, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21180 · Cited by 42

Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis

Li, L., Guturi, K. K. N., Gautreau, B., Patel, P. S., Saad, A., Morii, M., Mateo, F., Palomero, L., Barbour, H., Gómez, A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120401 · Cited by 41

SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line

Lingrand, M., Lalonde, S., Jutras-Carignan, A., Bergeron, K., Rassart, É., & Mounier, C. (2020) · Breast Cancer · doi:10.1007/s12282-020-01053-8 · Cited by 42

METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B

Hu, Y., Li, Y., Huang, Y., Jin, Z., Wang, C., Wang, H., & Xu, J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173134 · Cited by 41

miR-16-5p/PDK4-Mediated Metabolic Reprogramming Is Involved in Chemoresistance of Cervical Cancer

Zhao, Z., Ji, M., Wang, Q., He, N., & Li, Y. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.05.008 · Cited by 41

Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

Conti, L., Bolli, E., Lorenzo, A. D., Franceschi, V., Macchi, F., Riccardo, F., Ruiu, R., Russo, L., Quaglino, E., Donofrío, G., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0082 · Cited by 42

Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value

Fahim, S. A., Abdullah, M. S., Espinoza‐Sánchez, N. A., Hassan, H., Ibrahim, A. M., Ahmed, S. H., Shakir, G., Badawy, M. A., Zakhary, N. I., Greve, B., et al. (2020) · Biomolecules · doi:10.3390/biom10071059 · Cited by 41

GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer

Shin, E. M., Huynh, V. T., Neja, S. A., Liu, C. Y., Raju, A., Tan, K. Y. S., Tan, N. S., Gunaratne, J., Bi, X., Iyer, L. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe2470 · Cited by 43

Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing

Mosharaf, M. P., Reza, M. S., Kibria, M. K., Ahmed, F. F., Kabir, M. H., Hasan, S., & Mollah, M. N. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-08073-8 · Cited by 41

The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells

Liu, C.-Y., Huang, T.-T., Chu, P.-Y., Huang, C.-T., Lee, C.-H., Wang, W.-L., Lau, K.-Y., Tsai, W.-C., Chao, T.-I., Su, J.-C., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.114 · Cited by 40

Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients

Sun, Y., Zhang, Y., Ren, S., Li, X., Yang, P., Zhu, J., Lin, L., Wang, Z., & Jia, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106454 · Cited by 41

Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis

Ma, J., Chen, C., Liu, S., Ji, J., Wu, D., Huang, P. F., Wei, D., Fan, Z., & Ren, L. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00473-2 · Cited by 40

ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer

Madhavan, S., Gusev, Y., Singh, S., & Riggins, R. B. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0150-9 · Cited by 42

Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis

Leyh, B., Dittmer, A., Lange, T., Martens, J. W. M., & Dittmer, J. (2015) · Oncotarget · doi:10.18632/oncotarget.5624 · Cited by 40

MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer

Cho, C.-Y., Lee, K., Chen, W.-C., Wang, C., Chang, Y.-S., Huang, H.-L., Hsu, H., Yen, M., Lai, M., & Lai, M.-D. (2016) · Oncotarget · doi:10.18632/oncotarget.7542 · Cited by 40

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

Liu, C., Huang, T., Huang, C., Hu, M.-H., Wang, D., Wang, W., Tsai, W.-C., Lee, C., Lau, K.-Y., Yang, H., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.11.012 · Cited by 40

A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease

Pinto, J. A., Araujo, J. M., Cardenas, N. K., Morante, Z., Doimi, F. D., Vidaurre, T., Balko, J. M., & Gómez, H. (2016) · npj Genomic Medicine · doi:10.1038/npjgenmed.2015.15 · Cited by 40

The CCR2 3′UTR functions as a competing endogenous RNA to inhibit breast cancer metastasis

Hu, J., Li, X., Guo, X., Guo, Q., Xiang, C., Zhang, Z., Xing, Y., Xi, T., & Zheng, L. (2017) · Journal of Cell Science · doi:10.1242/jcs.202127 · Cited by 40

The Complex Subtype-Dependent Role of Connexin 43 (GJA1) in Breast Cancer

Busby, M., Hallett, M. T., & Plante, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030693 · Cited by 43

Distinct lung cancer subtypes associate to distinct drivers of tumor progression

Relli, V., Trerotola, M., Guerra, E., & Alberti, S. (2018) · Oncotarget · doi:10.18632/oncotarget.26217 · Cited by 40

Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells

Bellissimo, T., Tito, C., Ganci, F., Sacconi, A., Masciarelli, S., Martino, G. D., Porta, N., Cirenza, M., Sorci, M., Angelis, L. D., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1267-5 · Cited by 40

DDR1 and MT1-MMP Expression Levels Are Determinant for Triggering BIK-Mediated Apoptosis by 3D Type I Collagen Matrix in Invasive Basal-Like Breast Carcinoma Cells

Saby, C., Collin, G., Sinane, M., Buache, É., Gulick, L. V., Saltel, F., Maquoi, E., & Morjani, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00462 · Cited by 39

The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma

Lin, S., Huang, C., Sun, J., Bollt, O., Wang, X., Martine, E., Kang, J., Taylor, M. D., Fang, B., Singh, P. K., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910849 · Cited by 38

Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin–proteasomal degradation of COX-2

Pan, T., Zhou, D., Shi, Z., Qiu, Y., Zhou, G., Liu, J., Yang, Q., Cao, L., & Zhang, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.003 · Cited by 40

Dietary Antioxidant Trans-Cinnamaldehyde Reduced Visfatin-Induced Breast Cancer Progression: In Vivo and In Vitro Study

Chiang, Y., Chen, H.-Y., Huang, K., Lin, P., & Hsia, S. (2019) · Antioxidants · doi:10.3390/antiox8120625 · Cited by 39

Identification of Distinct Heterogenic Subtypes and Molecular Signatures Associated with African Ancestry in Triple Negative Breast Cancer Using Quantified Genetic Ancestry Models in Admixed Race Populations

Davis, M. B., Martini, R. N., Newman, L. A., Elemento, O., White, J. A., Verma, A., Datta, I., Adrianto, I., Chen, Y., Gardner, K. L., et al. (2020) · Cancers · doi:10.3390/cancers12051220 · Cited by 40

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer

Walsh, C. A., Akrap, N., Garré, E., Magnusson, Y., Harrison, H., Andersson, D., Jonasson, E., Rafnsdóttir, S., Choudhry, H., Buffa, F. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236187 · Cited by 41

Hormonal Regulation of Semaphorin 7a in ER+ Breast Cancer Drives Therapeutic Resistance

Crump, L. S., Wyatt, G. L., Rutherford, T. R., Richer, J. K., Porter, W. W., & Lyons, T. R. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1601 · Cited by 40

NEFM DNA methylation correlates with immune infiltration and survival in breast cancer

Li, D., Zhao, W., Zhang, X., Lv, H., Li, C., & Sun, L. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01096-4 · Cited by 42

SLC7A5 serves as a prognostic factor of breast cancer and promotes cell proliferation through activating AKT/mTORC1 signaling pathway

Li, Y., Wang, W., Wu, X., Ling, S., Ma, Y., & Huang, P. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2247 · Cited by 40

Quercetin Impairs HuR-Driven Progression and Migration of Triple Negative Breast Cancer (TNBC) Cells

Umar, S. M., Patra, S., Kashyap, A., R, A. D. J., Kumar, L., & Prasad, C. P. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1952628 · Cited by 40

The Antitriple Negative Breast cancer Efficacy of Spatholobus suberectus Dunn on ROS‐Induced Noncanonical Inflammasome Pyroptotic Pathway

Zhang, F., Liu, Q., Ganesan, K., Kewu, Z., Shen, J., Fang, G., Luo, X., & Chen, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5187569 · Cited by 40

CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis

Truesdell, P. F., Ahn, J. C., Chander, H., Meens, J., Watt, K., Yang, X., & Craig, A. W. (2014) · Oncogene · doi:10.1038/onc.2014.280 · Cited by 40

MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer

Yamashita, N., Morimoto, Y., Fushimi, A., Ahmad, R., Bhattacharya, A., Daimon, T., Haratake, N., Inoue, Y., Ishikawa, S., Yamamoto, M., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0772 · Cited by 39

Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages

Sun, R., Lei, C., Xu, Z., Gu, X., Huang, L., Chen, L., Tan, Y., Peng, M., Yaddanapudi, K., Siskind, L. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45084-7 · Cited by 43

Potentials of peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases

Singh, A., & Chaudhary, R. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114616 · Cited by 42

New network topology approaches reveal differential correlation patterns in breast cancer

Bockmayr, M. L., Klauschen, F., Győrffy, B., Denkert, C., & Budczies, J. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-78 · Cited by 39

MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells

Kim, S., Lee, J., Jeon, M., Lee, J. E., & Nam, S. J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4345-7 · Cited by 39

The voltage gated Ca2+-channel Cav3.2 and therapeutic responses in breast cancer

Pera, E., Kaemmerer, E., Milevskiy, M. J. G., Yapa, K. T. D. S., O’Donnell, J. S., Brown, M. A., Simpson, F., Peters, A. A., Roberts‐Thomson, S. J., & Monteith, G. R. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0299-0 · Cited by 39

The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression

Lo, P., Lee, J. S., Liang, X., & Sukumar, S. V. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.06.021 · Cited by 39

Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion

Berens, E. B., Sharif, G. M., Schmidt, M. O., Yan, G., Shuptrine, C. W., Weiner, L. M., Glasgow, E. F., Riegel, A. T., & Wellstein, A. (2016) · Oncogene · doi:10.1038/onc.2016.234 · Cited by 39

CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling

Lin, C., Liao, W., Jian, Y., Peng, Y., Zhang, X., Ye, L., Cui, Y.-L., Wang, B., Wu, X., Xiong, Z., et al. (2017) · Oncogene · doi:10.1038/onc.2016.525 · Cited by 39

Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion

Annis, M. G., Ouellet, V., Rennhack, J. P., L’Espérance, S., Rancourt, C., Mes‐Masson, A., Andrechek, E. R., & Siegel, P. M. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0936-8 · Cited by 39

DNA methylation signatures of Prostate Cancer in peripheral T-cells

Mehdi, A., Cheishvili, D., Arakelian, A., Bismar, T., Szyf, M., & Rabbani, S. (2018) · BMC Cancer · doi:10.1186/s12885-020-07078-8 · Cited by 18

MORC4 is a novel breast cancer oncogene regulated by miR‐193b‐3p

Yang, Z., Zhuang, Q., Hu, G., & Geng, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27751 · Cited by 39

Grade-specific diagnostic and prognostic biomarkers in breast cancer

Jayanthi, V. S. P. K. S. A., Das, A. B., & Saxena, U. (2019) · Genomics · doi:10.1016/j.ygeno.2019.03.001 · Cited by 39

Identification of an AP1-ZFP36 Regulatory Network Associated with Breast Cancer Prognosis

Canzoneri, R., Naipauer, J., Stedile, M., Rodríguez‐Pena, A., Lacunza, E., Gandini, N. A., Curino, A. C., Facchinetti, M. M., Coso, O. A., Kordon, E. C., et al. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09448-1 · Cited by 38

The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer

Gibbs, Z. A., Reza, L. C., Cheng, C.-C., Westcott, J. M., McGlynn, K., & Whitehurst, A. W. (2020) · eLife · doi:10.7554/elife.57679 · Cited by 38

Quinolinate Phosphoribosyltransferase Promotes Invasiveness of Breast Cancer Through Myosin Light Chain Phosphorylation

Liu, C., Cheng, S., Chen, M., Lin, C., Shan-na, C., Kuo, Y.-H., & Chang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.621944 · Cited by 40

Expression and prognostic values of ARID family members in breast cancer

Zhang, J., Hou, S., You, Z., Li, G., Xu, S., Li, X., Zhang, X., Lei, B., & Pang, D. (2021) · Aging · doi:10.18632/aging.202489 · Cited by 39

Zinc finger protein E4F1 cooperates with PARP-1 and BRG1 to promote DNA double-strand break repair

Moison, C., Chagraoui, J., Caron, M., Gagné, J., Coulombe, Y., Poirier, G. G., Masson, J., & Sauvageau, G. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019408118 · Cited by 39

LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication

Sheng, X., Dai, H., Du, Y., Peng, J., Sha, R., Yang, F., Zhou, L., Lin, Y., Xu, S., Wu, Y., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02015-4 · Cited by 39

DNA methylation signatures of breast cancer in peripheral T-cells

Parashar, S., Cheishvili, D., Mahmood, N., Arakelian, A., Tanvir, I., Khan, H. A., Kremer, R. B., Mihalcioiu, C. L. D., Moshe Szyf, A., & Rabbani, S. A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4482-7 · Cited by 39

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments

Miranda, M. S., Rozali, E. N., Khanna, K. K., & Al‐Ejeh, F. (2015) · Oncoscience · doi:10.18632/oncoscience.135 · Cited by 39

Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer

You, Q., Xu, D., & Guo, H. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s87197 · Cited by 38

Global characterization of signalling networks associated with tamoxifen resistance in breast cancer

Browne, B. C., Hochgräfe, F., Wu, J., Millar, E. K. A., Barraclough, J., Stone, A. M., McCloy, R. A., Lee, C. S., Roberts, C., Ali, N., et al. (2013) · FEBS Journal · doi:10.1111/febs.12441 · Cited by 38

Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells

Redmond, A. M., Byrne, C., Bane, F., Brown, G. D., Tibbitts, P., O’Brien, K., Hill, A. D. K., Carroll, J. S., & Young, L. S. (2014) · Oncogene · doi:10.1038/onc.2014.323 · Cited by 38

Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer

Sänger, N., Ruckhäberle, E., Győrffy, B., Engels, K., Heinrich, T. M., Fehm, T. N., Graf, A., Holtrich, U., Becker, S., & Karn, T. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.016 · Cited by 38

Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab

Cañas, A., Lopez-Sanchez, L. M., Peñarando, J., Valverde, A. M., Conde, F., Hernandez, V. A., Fuentes, E., López-Pedrera, C., de la Haba-Rodríguez, J., Aranda, E., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.02.005 · Cited by 38

miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma

Zhang, H., Alshareef, A., Wu, C., Jiao, J.-W., Sorensen, P. H. B., Lai, R. L., Xu, L., & Li, E. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw079 · Cited by 38

Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes

Dobroff, A. S., D’Angelo, S., Eckhardt, B. L., Ferrara, F., Staquicini, D. I., Cardó‐Vila, M., Staquicini, F. I., Nunes, D. N., Kim, K.-S., Driessen, W. H. P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615288113 · Cited by 38

Mining heterogeneous causal effects for personalized cancer treatment

Zhang, W., Le, T. D., Liu, L., Zhou, Z., & Li, J. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx174 · Cited by 36

Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells

Castiello, L., Sestili, P., Schiavoni, G., Dattilo, R., Monque, D. M., Ciaffoni, F., Iezzi, M., Lamolinara, A., Sistigu, A., Moschella, F., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0675 · Cited by 38

Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress

Lin, C., Beattie, A., Baradaran, B., Dray, E. V., & Duijf, P. H. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-32272-x · Cited by 38

Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes

Sun, L., He, M., Xu, N., Xu, D., Ben‐David, Y., Yang, Z., & Li, Y. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4571 · Cited by 38

New Insight on Solute Carrier Family 27 Member 6 (SLC27A6) in Tumoral and Non-Tumoral Breast Cells

Yen, M., Chou, S., Kan, J., Kuo, P., Hou, M., & Hsu, Y. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.29946 · Cited by 38

Grainyhead-like Protein 2: The Emerging Role in Hormone-Dependent Cancers and Epigenetics

Reese, R., Harrison, M. M., & Alarid, E. T. (2019) · Endocrinology · doi:10.1210/en.2019-00213 · Cited by 38

A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors

Pérez‐Peña, J., Fekete, J. T., Páez, R., Baliu‐Piqué, M., García-Sáenz, J. Á., García‐Barberán, V., Manzano, A., Pérez‐Segura, P., Esparı́s-Ogando, A., Pandiella, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02802 · Cited by 39

Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells

Pu, Q., Lv, Y., Dong, K., Geng, W., & Gao, H. (2020) · BMC Cancer · doi:10.1186/s12885-020-07069-9 · Cited by 40

Collective invasion induced by an autocrine purinergic loop through connexin-43 hemichannels

Khalil, A., Ilina, O., Vasaturo, A., Venhuizen, J., Vullings, M., Venhuizen, V., Bilos, A., Figdor, C. G., Span, P. N., & Friedl, P. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201911120 · Cited by 39

Identification of spliceosome components pivotal to breast cancer survival

An, J., Luo, Z., An, W., Cao, D., Ma, J., & Liu, Z. (2020) · RNA Biology · doi:10.1080/15476286.2020.1822636 · Cited by 38

Interleukin 32 Promotes Foxp3+ Treg Cell Development and CD8+ T Cell Function in Human Esophageal Squamous Cell Carcinoma Microenvironment

Li, H., Chen, S., Chen, Z., Zhou, B., Zheng, Y., & Shen, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.704853 · Cited by 38

Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal adhesion dynamics

Bugide, S., David, D., Nair, S. A., Kannan, N., Samanthapudi, V. S. K., Prabhakar, J., & Manavathi, B. (2014) · Oncogene · doi:10.1038/onc.2014.389 · Cited by 38

Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion

Li, X. L., Lu, X., Parvathaneni, S., Bilke, S., Zhang, H., Thangavel, S., Vindigni, A., Hara, T., Zhu, Y. J., Meltzer, P. S., et al. (2014) · Cell Cycle · doi:10.4161/cc.29419 · Cited by 37

High level PHGDH expression in breast is predominantly associated with keratin 5‐positive cell lineage independently of malignancy

Gromova, I., Gromov, P., Honma, N., Kumar, S., Rimm, D. L., Talman, M., Wielenga, V. T., & Moreira, J. M. A. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.05.003 · Cited by 36

The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers

Li, Y., Huang, J., Sun, J., Xiang, S., Yang, D., Ying, X., Lu, M., Li, H., & Ren, G. (2016) · Oncotarget · doi:10.18632/oncotarget.13885 · Cited by 37

The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells

Muluhngwi, P., Alizadeh‐Rad, N., Vittitow, S. L., Kalbfleisch, T., & Klinge, C. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-05727-w · Cited by 37

PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer

Wang, Y., Zhang, C., Mai, L., Niu, Y., Wang, Y., & Bu, Y. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.2.207 · Cited by 37

AKR1C1‑3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies

Zhao, S., Wagn, S., Zhao, Z., & Li, W. (2019) · Oncology Letters · doi:10.3892/ol.2019.10802 · Cited by 37

The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs

Brown, J. M., Wasson, M. D., & Marcato, P. (2020) · Cells · doi:10.3390/cells9030763 · Cited by 39

Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages

Amjad, E., Asnaashari, S., Sokouti, B., & Dastmalchi, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67643-w · Cited by 36

Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model

Vargas, J. E., Puga, R., Lenz, G., Trindade, C., & Filippi‐Chiela, E. C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5432651 · Cited by 37

Epigenetic modification and a role for the E3 ligase RNF40 in cancer development and metastasis

Fu, J., Liao, L., Balaji, K. S., Wei, C., Kim, J., & Peng, J. (2020) · Oncogene · doi:10.1038/s41388-020-01556-w · Cited by 40

Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer

Oo, K. K., Kamolhan, T., Soni, A., Thongchot, S., Mitrpant, C., O-Charoenrat, P., Thuwajit, C., & Thuwajit, P. (2020) · BMC Cancer · doi:10.1186/s12885-020-07761-w · Cited by 39

High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer

Li, H., Wang, C., Lan, L., Behrens, A., Tomaschko, M., Ruiz, J., Su, Q., Zhao, G., Yuan, C., Xiao, X., et al. (2021) · Aging · doi:10.18632/aging.202440 · Cited by 37

Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression

Provance, O. K., Geanes, E. S., Lui, A. J., Roy, A., Holloran, S. M., Gunewardena, S., Hagan, C. R., Weir, S. J., & Lewis-Wambi, J. S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.006 · Cited by 37

CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma

Lin, T., Zhang, E., Mai, P., Zhang, Y.-Z., Chen, X. '., & Peng, L.-S. (2021) · Bioscience Reports · doi:10.1042/bsr20204312 · Cited by 37

Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation

Tang, Y. H., Rockstroh, A., Sokolowski, K. A., Lynam, L.-R., Lehman, M., Thompson, E. W., Gregory, P. A., Nelson, C. C., Volpert, M., & Hollier, B. G. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01501-7 · Cited by 39

P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-p1-07-18 · Cited by 70

Online biomarker validation of survival-associated biomarkers in breast and ovarian cancer using microarray data of 3,862 patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.10571

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 2,024

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

van Laar, R. K. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.003 · Cited by 12

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Jézéquel, P., Campone, M., Gouraud, W., Guérin‐Charbonnel, C., Leux, C., Ricolleau, G., & Campion, L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1457-7 · Cited by 410